Atlas Trials

A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus

Clinical trial NCT01702740 · COMPLETED

Trial details

NCT number
NCT01702740
Sponsor
Centocor Research & Development, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lupus Erythematosus, CutaneousLupus Erythematosus, Systemic
Start date
2007-03-01
Primary completion
2009-10-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.